发明名称 Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers
摘要 Methods and compositions are provided for modulating Hedgehog (Hh) pathway signaling in a cell. Aspects of the methods include methods for inhibiting Hh pathway-promoted cancer proliferation and/or metastasis that is promoted by Hh pathway signaling, methods for treating cancers promoted by Hh pathway signaling, and methods for screening candidate agents for the ability to treat a cancer promoted by Hh pathway signaling. In addition, reagents and kits thereof that find use in practicing the subject methods are provided.
申请公布号 US9073964(B2) 申请公布日期 2015.07.07
申请号 US201213422936 申请日期 2012.03.16
申请人 The Board of Trustees of the Leland Stanford Junior University 发明人 Atwood Scott X.;Oro Anthony
分类号 A61K39/00;C07K7/06;C07K7/08;C07D403/12;A61K31/713;C07D491/107;C07D211/40;C12N15/113 主分类号 A61K39/00
代理机构 Bozicevic, Field & Francis LLP 代理人 Baba Edward J.;Chandra Shweta;Bozicevic, Field & Francis LLP
主权项 1. A method of inhibiting Hedgehog (Hh) pathway-promoted cancer cell proliferation, comprising: determining Gli activity in a cancer cell to identify the cancer cell as a Hh-induced cancer cell, wherein Gli activity is increased in the Hh-induced cancer cell and aPKC iota activates Gli; contacting the Hh-induced cancer cell with an aPKC iota antagonist in an amount effective to inhibit Hh pathway-induced proliferation of the cell, wherein the aPKC iota antagonist consists essentially of SEQ ID NO:4.
地址 Palo Alto CA US